Lakefront Biotherapeutics NV (LKFT)

LKFT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,863	2,166	1,809	2,694	2,909	3,669
Market Cap Growth	-	19.74%	-32.85%	-7.39%	-20.71%	-43.02%
Enterprise Value	-1,640	-1,406	-1,635	-1,503	-1,728	-1,844
Last Close Price	27.73	32.70	27.50	40.65	44.38	55.13
PE Ratio	3.34	5.75	23.59	11.51	-	-
PS Ratio	1.55	1.66	6.34	10.17	11.28	13.77
PB Ratio	0.50	0.57	0.60	0.87	1.08	1.22
P/TBV Ratio	0.50	0.57	0.66	0.94	1.17	1.24
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.01	0.01
Debt / EBITDA Ratio	0.01	0.01	-	-	-	-
Net Debt / Equity Ratio	-0.91	-0.92	-1.07	-1.31	-1.61	-1.77
Net Debt / EBITDA Ratio	-4.49	-5.26	20.26	88.61	62.18	28.64
Net Debt / FCF Ratio	9.59	11.03	9.22	8.65	7.71	8.38
Asset Turnover	0.28	0.30	0.07	0.05	0.05	0.04
Inventory Turnover	17.09	13.28	5.92	3.80	7.34	30.64
Quick Ratio	30.24	19.96	9.57	8.76	7.98	8.53
Current Ratio	30.48	20.15	9.97	9.02	8.11	8.58
Return on Equity (ROE)	16.26%	10.42%	-0.04%	-0.15%	-2.76%	-4.55%
Return on Assets (ROA)	10.66%	8.87%	-2.75%	-1.17%	-1.65%	-1.97%
Return on Invested Capital (ROIC)	241.35%	2988.46%	-	-	-	-
Return on Capital Employed (ROCE)	19.30%	16.50%	-4.90%	-2.20%	-3.10%	-3.70%
Earnings Yield	30.25%	17.39%	4.24%	8.69%	-8.01%	-3.20%
FCF Yield	-19.62%	-14.70%	-19.27%	-17.42%	-19.39%	-17.29%
Buyback Yield / Dilution	-0.03%	0.06%	-0.01%	-0.36%	-0.30%	-0.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.